Libre Life aims to ensure factual accuracy in its editorial content.
We cover diabetes medtech, CGM developments, hybrid-closed loop systems, insulin pump technology, product announcements, regulatory developments and practical real-world device use.
Technology timelines, product specifications, regulatory approvals and commercial plans can change. Where new information becomes available, we may update articles to reflect the latest information.
Corrections and updates
If a factual error is identified, we aim to review it and make corrections where appropriate.
This may include:
- factual clarifications
- corrections to dates or timelines
- updated technical specifications
- revised product availability information
- updated regulatory or manufacturer information
- removal or amendment of inaccurate statements
Material corrections may be reflected within the article.
Minor edits for clarity, formatting or readability may be made without a specific correction notice.
Commentary and opinion
Some Libre Life content includes editorial analysis, commentary and opinion.
Corrections relate to factual accuracy rather than editorial interpretation or opinion.
Reporting a correction
If you believe an article contains a factual error, please contact us with:
- the article title or URL
- the information you believe is incorrect
- the suggested correction or source where relevant
Correction requests can be submitted via our contact page:
https://lovemylibre.com/pages/contact
Editorial responsibility
Libre Life is published by Love My Libre Ltd.
Editorial content is reviewed and updated in line with our editorial standards where appropriate.
For further information, please see our Editorial Policy.